| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0076-6879(04)82018-4 |
| P698 | PubMed publication ID | 15047110 |
| P2093 | author name string | Asher Begleiter | |
| Jeanne Fourie | |||
| P2860 | cites work | Studies with 1,2-dithiole-3-thione as a chemoprotector of hydroquinone-induced toxicity to DBA/2-derived bone marrow stromal cells | Q23922986 |
| A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure | Q24562666 | ||
| Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates | Q24563653 | ||
| Factors influencing the induction of DT-diaphorase activity by 1,2-dithiole-3-thione in human tumor cell lines | Q42502343 | ||
| Increased sensitivity of quinone resistant cells to mitomycin C. | Q43489905 | ||
| Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones | Q43620555 | ||
| Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione | Q44558233 | ||
| The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233). | Q50772616 | ||
| Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: A screening assay for anticarcinogenic enzyme inducers | Q50897350 | ||
| Bioreductive activation of a series of indolequinones by human DT-diaphorase: structure-activity relationships. | Q52536584 | ||
| Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: differences in in vitro and in vivo systems. | Q52833998 | ||
| Role of cytochrome P1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. | Q53527232 | ||
| Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard. | Q53535151 | ||
| Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. | Q55067740 | ||
| Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation | Q59587789 | ||
| Indolequinone antitumor agents: Relationship between quinone structure and rate of metabolism by recombinant human NQO1 | Q60407945 | ||
| Induction of Phase I and Phase II Drug-Metabolizing Enzyme mRNA, Protein, and Activity by BHA, Ethoxyquin, and Oltipraz | Q64445203 | ||
| Bioactivation of Mitomycin C by Xanthine Dehydrogenase From EMT6 Mouse Mammary Carcinoma Tumors | Q68215863 | ||
| Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol | Q68716870 | ||
| Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA | Q70329806 | ||
| Distribution of newly synthesized DT-diaphorase in rat liver | Q70560517 | ||
| Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1 | Q70919504 | ||
| Bioactivation of mitomycin antibiotics by aerobic and hypoxic Chinese hamster ovary cells overexpressing DT-diaphorase | Q71210020 | ||
| Induction of DT-diaphorase by doxorubicin and combination therapy with mitomycin C in vitro | Q71561174 | ||
| Glutathione S-transferases of female A/J mouse liver and forestomach and their differential induction by anti-carcinogenic organosulfides from garlic | Q71858979 | ||
| Recent Advances in the Usage of Mitomycin. Proceedings of a symposium. Hawaii, March 21-24, 1991 | Q72217529 | ||
| Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines | Q72464961 | ||
| Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones | Q72785988 | ||
| Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies | Q73553696 | ||
| The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant | Q73626779 | ||
| Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China | Q74528273 | ||
| DT diaphorase. II. Relation to respiratory chain of intact mitochondira | Q79369311 | ||
| Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain | Q24609907 | ||
| Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene | Q24649776 | ||
| Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches | Q27636626 | ||
| Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene | Q28204923 | ||
| An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements | Q28244853 | ||
| Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes | Q28292606 | ||
| Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin | Q28304365 | ||
| Differences in induction by xenobiotics in murine tissues and the Hepa1c1c7 cell line of mRNAs encoding glutathione transferase, quinone reductase, and CYP1A P450s. | Q30466699 | ||
| Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis | Q33665840 | ||
| Clinical applications of quinone-containing alkylating agents | Q33923566 | ||
| Regulation of genes encoding NAD(P)H:quinone oxidoreductases | Q34062702 | ||
| Design and synthesis of bifunctional isothiocyanate analogs of sulforaphane: correlation between structure and potency as inducers of anticarcinogenic detoxication enzymes | Q34348301 | ||
| DT-diaphorase and cancer chemotherapy | Q36066319 | ||
| Chemical and molecular regulation of enzymes that detoxify carcinogens | Q36210195 | ||
| Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609 | Q36292387 | ||
| Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents | Q36292457 | ||
| Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). | Q36419978 | ||
| Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy | Q36431150 | ||
| Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase | Q36618045 | ||
| Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09. | Q36751567 | ||
| Functional antioxidant responsive elements. | Q36772872 | ||
| Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz | Q37359368 | ||
| On the mechanisms of induction of cancer-protective enzymes: a unifying proposal | Q37558012 | ||
| The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle | Q38293198 | ||
| Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression. Effect of sulfhydryl modifying agents | Q38302452 | ||
| NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues | Q38318799 | ||
| Studies on the reaction mechanism of DT diaphorase. Action of dead-end inhibitors and effects of phospholipids | Q39349022 | ||
| The chemotherapy of schistosomiasis | Q39821865 | ||
| Pulmonary toxicity of antineoplastic agents: Anaesthetic and postoperative implications | Q40153175 | ||
| Antioxidant response element | Q40693112 | ||
| The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase | Q40748429 | ||
| The electrophile counterattack response: protection against neoplasia and toxicity. | Q40837888 | ||
| Cellular pharmacology of quinone bioreductive alkylating agents | Q40848126 | ||
| The experimental development of bioreductive drugs and their role in cancer therapy. | Q40848141 | ||
| DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. | Q40848147 | ||
| Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. | Q41218087 | ||
| DT-diaphorase activity and the cytotoxicity of quinones in C3H/10T1/2 mouse embryo cells | Q41253198 | ||
| Characterization of quinone reductase, glutathione and glutathione S-transferase in human myeloid cell lines: induction by 1,2-dithiole-3-thione and effects on hydroquinone-induced cytotoxicity | Q41507227 | ||
| Effects of 5-azacytidine and methyl-group deficiency on NAD(P)H: quinone oxidoreductase and glutathione S-transferase in liver | Q41964013 | ||
| Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione: effect on hydroquinone-induced cytotoxicity | Q42454021 | ||
| Induction of NAD(P)H:quinone reductase in human peripheral blood lymphocytes | Q42463662 | ||
| Disruption of c-Fos leads to increased expression of NAD(P)H:quinone oxidoreductase1 and glutathione S-transferase | Q42467001 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 320-351 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Methods in Enzymology | Q2076903 |
| P1476 | title | Induction of NQO1 in cancer cells | |
| P478 | volume | 382 |
| Q35128280 | Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein. |
| Q36695591 | An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis |
| Q35880201 | An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone |
| Q40960687 | CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation |
| Q40268641 | Can dicoumarol be used as a gonad-safe anticancer agent: an in vitro and in vivo experimental study |
| Q46764785 | Combination chemoprevention of hamster buccal pouch carcinogenesis by bovine milk lactoferrin and black tea polyphenols |
| Q34551489 | Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage |
| Q37015352 | Enhancement of radiation effect using beta-lapachone and underlying mechanism |
| Q39816199 | Heat shock increases expression of NAD(P)H:quinone oxidoreductase (NQO1), mediator of beta-lapachone cytotoxicity, by increasing NQO1 gene activity and via Hsp70-mediated stabilisation of NQO1 protein |
| Q39633123 | Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells |
| Q53067235 | Modulatory effect of troxerutin on biotransforming enzymes and preneoplasic lesions induced by 1,2-dimethylhydrazine in rat colon carcinogenesis. |
| Q38800714 | NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 4-aminoquinazoline derivatives |
| Q60948295 | NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress |
| Q39950825 | Nrf2-mediated induction of detoxifying enzymes by alantolactone present in Inula helenium |
| Q37681911 | Pretreatment with black tea polyphenols modulates xenobiotic-metabolizing enzymes in an experimental oral carcinogenesis model. |
| Q37122089 | Structure, function, and mechanism of cytosolic quinone reductases |
| Q35945059 | Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells |
Search more.